Published in Blood Weekly, November 1st, 1999
S.M. Muller and colleagues at Germany's University Ulm, Children's Hospital, said the aim of their study was to reduce the rate of graft failure after HLA non-identical stem cell transplantation by using G-CSF mobilized CD34+ peripheral blood progenitor cells (PBPC), either in combination with bone marrow or as single grafts.
Muller et al. published their study in Bone Marrow Transplantation ("Definition of a Critical T-Cell Threshold for Prevention of GVHD...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.